LDLR and infection: Likewise, pre-treatment of cells with the proprotein convertase subtilisin-like kexin type nine (PCSK9), which, by binding to EGF-like repeats, can inhibit LDL-R recycling and thus LDL-R at the cell surface (96), was shown to inhibit HCV (97) and CCHFV (64) infection.